Antithrombotic therapy in patients with atrial fibrillation and coronary artery disease
Atrial fibrillation and coronary artery disease are commonly coexisting conditions that necessitate the use of an oral anticoagulant as well as dual antiplatelet therapy. Commonly referred to as triple oral antithrombotic therapy (TT), this helps prevent ischemic stroke and myocardial infarction but...
Guardado en:
Autores principales: | Abdelmoniem Moustafa, Mohammad Ruzieh, Ehab Eltahawy, Saima Karim |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/744980a3a9724d1cb85acc9fb9d3f2b4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Safety and efficacy of dual versus triple antithrombotic therapy in Patients with atrial fibrillation undergoing percutaneous coronary intervention: a meta-analysis
por: Abdelmoniem Moustafa, et al.
Publicado: (2020) -
Antithrombotic therapy in very elderly patients with atrial fibrillation: Is it enough to assess thromboembolic risk?
por: Yutao Guo, et al.
Publicado: (2010) -
Antithrombotic therapies for elderly patients: handling problems originating from their comorbidities
por: Arahata M, et al.
Publicado: (2018) -
Management of patients with arterial hypertension and atrial fibrillation
por: Irina E. Chazova, et al.
Publicado: (2021) -
Medical treatment and long-term outcome of chronic atrial fibrillation in the aged with chest distress: a retrospective analysis versus sinus rhythm
por: Guo Y, et al.
Publicado: (2011)